Rationale for Once-Daily Therapy in Asthma: Compliance Issues

Hyland, M.E.
December 1999
Drugs;Dec1999 Supplement 4, Vol. 58 Issue 6, p1
Academic Journal
Compliance in asthma is known to be poor. Once-daily treatment provides an additional therapeutic option for the clinician whose treatment aims include maximising treatment satisfaction and compliance. Once-daily treatment is preferred by some but not all patients and may lead to greater compliance in patients who are concerned about the effect of corticosteroids on their health. When switching to once-daily treatment, patients should be given a choice as to the time of treatment to minimise the impact of forgetting a dose.


Related Articles

  • Health-related quality of life assessment using St. George's respiratory questionnaire in asthmatics on inhaled corticosteroids. Sabin, Thomas; Parthasarathi, Gurumurthy; Padukudru, Mahesh A. // Lung India;Jan-Mar2012, Vol. 29 Issue 1, p35 

    Context: Chronic diseases like asthma have significant effects on patients' health-related quality of life (HRQoL). HRQoL measures additional indices as compared to objective measurements like spirometry. Aims: To assess and compare disease-specific quality of life in asthma patients using St....

  • QOL news from the 14th Annual Congress of the ERS.  // PharmacoEconomics & Outcomes News;11/6/2004, Issue 465, p8 

    Presents several studies of the effect of therapies for asthma on patients' quality of life (QOL). Evaluation of the efficacy and QOL effect of budenoside/thephylline therapy for asthma; Comparison on the use of salmeterol/fluticasone propionate and beclometasone among corticosteroid-dependent...

  • Inhaled corticosteroids and cataract: prevalence, prevention and management. Cumming, R.G.; Mitchell, P. // Drug Safety;Jan1999, Vol. 20 Issue 1, p77 

    Oral and topical (ocular) corticosteroids are known to have the potential to cause cataracts, but inhaled corticosteroids have generally been considered to be free of this adverse effect. However, a large epidemiological study has recently found a strong association in adults between use of...

  • Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma.  // Drugs & Therapy Perspectives;Nov2009, Vol. 25 Issue 11, p1 

    The corticosteroid budesonide and the long-acting β2-adrenoceptor agonist formoterol have been combined into a single pressurized metered-dose inhaler (pMDI). The combination pMDI improves lung function, asthma control, asthma symptoms and asthma-related quality of life outcomes in patients...

  • Clinical Significance of Asthma Clusters by Longitudinal Analysis in Korean Asthma Cohort. Park, So Young; Baek, Seunghee; Kim, Sujeong; Yoon, Sun-young; Kwon, Hyouk-Soo; Chang, Yoon-Seok; Cho, You Sook; Jang, An-Soo; Park, Jung Won; Nahm, Dong-Ho; Yoon, Ho-Joo; Cho, Sang-Heon; Cho, Young-Joo; Choi, ByoungWhui; Moon, Hee-Bom; Kim, Tae-Bum // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Background: We have previously identified four distinct groups of asthma patients in Korean cohorts using cluster analysis: (A) smoking asthma, (B) severe obstructive asthma, (C) early-onset atopic asthma, and (D) late-onset mild asthma. Methods and Results: A longitudinal analysis of each...

  • Measures of asthma control and quality of life: longitudinal data provide practical insights into their relative usefulness in different research contexts. King, Madeleine T.; Kenny, Patricia M.; Marks, Guy B. // Quality of Life Research;Apr2009, Vol. 18 Issue 3, p301 

    To further our understanding of the relationships between asthma control and health-related quality of life (HRQOL) and provide insights into the relative usefulness of various measures in different research contexts. We present a conceptual model and test it with longitudinal survey data....

  • Ciclesonide a breath of fresh air in asthma. Salmon, Kimberley // PharmacoEconomics & Outcomes News;5/7/2005, Issue 477, p3 

    Asthma is a chronic respiratory disease that occurs commonly in developed countries. The disease is associated with substantial morbidity and costs, and often greatly affects the quality of life (QOL) of patients. Inhaled corticosteroids have been the mainstay of asthma therapy for some time and...

  • Research backs parent-led treatment with asthma drug. Robinson, Stephen // GP: General Practitioner;3/12/2010, p24 

    The article cites a research on chemotherapy of asthmatic children, conducted by Dr. Peter Vuillermin and colleagues at Geelong Hospital in Australia. In this study, researchers concluded that acute asthma symptoms in young children can be reduced by early drug intervention by parents. It states...

  • Inhaled Mometasone Furoate: A Review of its Use in Persistent Asthma in Adults and Adolescents. McCormack, Paul L.; Plosker, Greg L. // Drugs;2006, Vol. 66 Issue 8, p1151 

    Inhaled mometasone furoate (Asmanex) is a synthetic corticosteroid indicated for the first-line maintenance prophylactic therapy of persistent asthma in adults and adolescents. It is formulated for delivery via a breath-actuated dry powder inhaler (DPI) [Twisthaler].Inhaled mometasone furoate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics